Afya (NASDAQ:AFYA – Get Free Report) will likely be announcing its earnings results before the market opens on Thursday, March 13th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $848.25 million for the quarter. Investors that wish to register for the company’s conference call can do so using this link.
Afya Trading Up 2.9 %
Shares of NASDAQ AFYA opened at $16.91 on Thursday. Afya has a twelve month low of $14.52 and a twelve month high of $22.24. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 0.51. The stock has a fifty day simple moving average of $16.28 and a 200-day simple moving average of $16.52. The stock has a market capitalization of $1.58 billion, a PE ratio of 13.64, a PEG ratio of 0.29 and a beta of 0.90.
Wall Street Analyst Weigh In
A number of equities research analysts have recently weighed in on AFYA shares. JPMorgan Chase & Co. dropped their price objective on Afya from $25.00 to $20.50 and set a “neutral” rating for the company in a research note on Friday, January 17th. The Goldman Sachs Group assumed coverage on Afya in a research note on Tuesday, December 3rd. They set a “sell” rating and a $16.00 target price for the company. Finally, Citigroup reissued a “sell” rating and set a $15.00 target price (down from $18.00) on shares of Afya in a research note on Friday, January 31st. Two investment analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $18.00.
Afya Company Profile
Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.
Featured Articles
- Five stocks we like better than Afya
- How Investors Can Find the Best Cheap Dividend Stocks
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Insider Trading – What You Need to Know
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- What is a Special Dividend?
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
